Literature DB >> 26328516

Cardiovascular disease and chronic kidney disease.

Richard Gargiulo, Faten Suhail, Edgar V Lerma.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26328516     DOI: 10.1016/j.disamonth.2015.07.005

Source DB:  PubMed          Journal:  Dis Mon        ISSN: 0011-5029            Impact factor:   3.800


× No keyword cloud information.
  16 in total

1.  Deoxycholic Acid, a Metabolite of Circulating Bile Acids, and Coronary Artery Vascular Calcification in CKD.

Authors:  Anna Jovanovich; Tamara Isakova; Geoffrey Block; Jason Stubbs; Gerard Smits; Michel Chonchol; Makoto Miyazaki
Journal:  Am J Kidney Dis       Date:  2017-08-09       Impact factor: 8.860

2.  Antihypertensive therapy prescribing patterns and correlates of blood pressure control among hypertensive patients with chronic kidney disease.

Authors:  Oyunbileg Magvanjav; Rhonda M Cooper-DeHoff; Caitrin W McDonough; Yan Gong; Mark S Segal; William R Hogan; Julie A Johnson
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-11-14       Impact factor: 3.738

3.  Thromboembolic and Hemorrhagic Outcomes in the Direct Oral Anticoagulant Trials Across the Spectrum of Kidney Function.

Authors:  Nita A Limdi; Timothy Mark Beasley; Jielin Sun; Norman Stockbridge; Michael Pacanowski; Jeffry Florian
Journal:  Clin Pharmacol Ther       Date:  2021-01-19       Impact factor: 6.903

Review 4.  Comparison of Drug-Eluting and Bare Metal Stents in Patients With Chronic Kidney Disease: An Updated Systematic Review and Meta-Analysis.

Authors:  Renjie Lu; Fenglei Tang; Yan Zhang; Xishan Zhu; Shanmei Zhu; Ganlin Wang; Yinfeng Jiang; Zhengda Fan
Journal:  J Am Heart Assoc       Date:  2016-11-07       Impact factor: 5.501

5.  A Primer on Quality Assurance and Performance Improvement for Interprofessional Chronic Kidney Disease Care: A Path to Joint Commission Certification.

Authors:  Linda Awdishu; Teri Moore; Michelle Morrison; Christy Turner; Danuta Trzebinska
Journal:  Pharmacy (Basel)       Date:  2019-07-03

Review 6.  Mild to moderate chronic kidney disease and cardiovascular events in patients with type 2 diabetes mellitus.

Authors:  Gayatri Lessey; Konstantinos Stavropoulos; Vasilios Papademetriou
Journal:  Vasc Health Risk Manag       Date:  2019-08-22

Review 7.  SPRINT: The Study Nephrologists Might Take With a Grain of Salt.

Authors:  Adrian Covic; Mugurel Apetrii; David Goldsmith; Mehmet Kanbay
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-07-01       Impact factor: 3.738

Review 8.  The Complexity of FGF23 Effects on Cardiomyocytes in Normal and Uremic Milieu.

Authors:  Andreja Figurek; Merita Rroji; Goce Spasovski
Journal:  Cells       Date:  2021-05-20       Impact factor: 6.600

Review 9.  Establishing the presence or absence of chronic kidney disease: Uses and limitations of formulas estimating the glomerular filtration rate.

Authors:  Ahmed Alaini; Deepak Malhotra; Helbert Rondon-Berrios; Christos P Argyropoulos; Zeid J Khitan; Dominic S C Raj; Mark Rohrscheib; Joseph I Shapiro; Antonios H Tzamaloukas
Journal:  World J Methodol       Date:  2017-09-26

Review 10.  Selective Peroxisome Proliferator-Activated Receptor Alpha Modulators (SPPARMα): New Opportunities to Reduce Residual Cardiovascular Risk in Chronic Kidney Disease?

Authors:  Jean-Charles Fruchart; Michel P Hermans; Jamila Fruchart-Najib
Journal:  Curr Atheroscler Rep       Date:  2020-07-15       Impact factor: 5.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.